NCT04123457
Biorepository of Biomarkers for Optimization of Microvascular Treatment of Lymphedema
Enrolling by Invitation
Not specifiedAges 18+ObservationalMayo ClinicInvestigator-initiated
~100 participants
Updated 2025-10-01 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Biospecimen Acquisition
Measured over 1 year
Conditions
Where it's being run
1 sites across 1 statesFlorida1
Study leadership
- Antonio Forte, MD, PhD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Adult (18+ years of age)
Ability to provide written consent
Has been diagnosed with Lymphedema
Exclusion
Under the age of 18 years old
Inability to provide written consent
Previous lymphovenous bypass or lymph node transfer surgery
Major changes occur to co-morbid conditions
Proven ICG or iodine allergy
What this trial measures
- Biospecimen Acquisition1 year
Number of biospecimens collected